Combine and Conquer: The Integration of Infectious Disease and Addiction Medicine
In this Q&A, Drs Serota and Thakarar discuss the dual subspecialty of infectious disease and addiction medicine and its role in combating the ongoing opioid epidemic.
Endocarditis
Combine and Conquer: A Treatment Strategy to Combat Drug-Use Associated Infections
Sandra Springer, MD, and Laura Marks, MD, PhD, highlight the need for a combined treatment approach for patients with drug-use associated infections.
Mortality Risk for Patients Receiving Antibiotics, Surgery for TAVI Infective Endocarditis
A study compared clinical characteristics and outcomes between patients with TAVI-IE treated with cardiac surgery and antibiotics and those treated with antibiotics only.
The Six Moments of Harm Reduction in Injection Drug Use: A Novel Educational Tool for Clinicians
Researchers assessed the effectiveness of the Six Moments of Harm Reduction, an educational tool for clinicians designed to improve knowledge on harm reduction and injection-associated infections.
Risk for Infective Endocarditis In Patients With Staphylococcus aureus Bloodstream Infections, Cancer
Investigators conducted a study to assess the incidence and risk factors associated with infective endocarditis in patients with and without active cancer.
Addressing Drug Use-Associated Infective Endocarditis
In a Q&A, Asher Schranz, MD, MPH, discusses the importance of physician collaboration in the treatment of patients with drug use-associated infective endocarditis.
Unique Risks in People With Familial Hypercholesterolemia and COVID-19
People with familial hypercholesterolemia with COVID-19 risk endothelial dysfunction. Therapy should continue during the course of the virus.
Comparison of Outcomes and Associated Costs of 4 Antibiotic Treatment Strategies for Drug-Use Associated Infective Endocarditis
Researchers conducted a study that compared clinical outcomes and cost-effectiveness of 4 antibiotic treatment strategies for patients with drug-use associated infective endocarditis.
Outcomes of Vancomycin Plus Ceftaroline Salvage Therapy in Patients With Persistent MRSA Bacteremia
Researchers conducted a study to assess the effects of vancomycin plus ceftaroline for the treatment of patients with persistent methicillin-resistant Staphylococcus aureus bacteremia.
Enterococcal Bacteremia and Potential Benefit of Infectious Disease Consultation
Researchers sought to determine whether an infectious disease consultation improves clinical outcomes and increases treatment adherence in patients infected with Enterococcus species.
- Loading...
Loading...
Loading... 
Loading...